BRPI0807613A2 - Ativação de antígeno humano presente em células através de clec-6 - Google Patents

Ativação de antígeno humano presente em células através de clec-6

Info

Publication number: BRPI0807613A2
Authority: BR; Brazil
Prior art keywords: clec; cells; human antigen; antigen activation; activation present
Prior art date: 2007-02-23

Application number

BRPI0807613-8A2A

Other languages

English (en)

Inventor

Jacques F Banchereau

Dapeng Li

Sandra Zurawski

Gerard Zurawski

Sangkon Oh

Original Assignee

Baylor Res Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-23

Filing date

2008-02-22

Publication date

2014-06-10

2008-02-22 Application filed by Baylor Res Inst filed Critical Baylor Res Inst

2014-06-10 Publication of BRPI0807613A2 publication Critical patent/BRPI0807613A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

BRPI0807613-8A2A 2007-02-23 2008-02-22 Ativação de antígeno humano presente em células através de clec-6 BRPI0807613A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US89141807P	2007-02-23	2007-02-23
PCT/US2008/054785 WO2008103947A2 (en)	2007-02-23	2008-02-22	Activation of human antigen-presenting cells through clec-6

Publications (1)

Publication Number	Publication Date
BRPI0807613A2 true BRPI0807613A2 (pt)	2014-06-10

Family

ID=39710781

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0807613-8A2A BRPI0807613A2 (pt)	2007-02-23	2008-02-22	Ativação de antígeno humano presente em células através de clec-6

Country Status (14)

Country	Link
US (1)	US20080254047A1 (pt)
EP (1)	EP2129692A4 (pt)
JP (1)	JP2010519313A (pt)
KR (1)	KR20090118981A (pt)
CN (2)	CN101668777A (pt)
AU (1)	AU2008218184B2 (pt)
BR (1)	BRPI0807613A2 (pt)
CA (1)	CA2717656A1 (pt)
IL (2)	IL200526A0 (pt)
MX (1)	MX2009008918A (pt)
NZ (2)	NZ595319A (pt)
TW (1)	TW200900078A (pt)
WO (1)	WO2008103947A2 (pt)
ZA (1)	ZA200906618B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20130036246A (ko) *	2010-05-07	2013-04-11	베일러 리서치 인스티튜트	사람 ｃｄ8+ ｔ 세포의 수지상 세포 면역수용체(ｄｃｉｒ)-매개 교차프라이밍
US9078878B2 (en)	2010-12-01	2015-07-14	Alderbio Holdings Llc	Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
MX359070B (es)	2010-12-01	2018-09-13	Alderbio Holdings Llc	Composiciones anti-ngf y uso de las mismas.
US9067988B2 (en)	2010-12-01	2015-06-30	Alderbio Holdings Llc	Methods of preventing or treating pain using anti-NGF antibodies
US9539324B2 (en)	2010-12-01	2017-01-10	Alderbio Holdings, Llc	Methods of preventing inflammation and treating pain using anti-NGF compositions
US11214610B2 (en)	2010-12-01	2022-01-04	H. Lundbeck A/S	High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US9884909B2 (en)	2010-12-01	2018-02-06	Alderbio Holdings Llc	Anti-NGF compositions and use thereof
JP6262218B2 (ja) *	2012-06-14	2018-01-17	エラスムスユニバーシティメディカルセンターロッテルダムＥｒａｓｍｕｓＵｎｉｖｅｒｓｉｔｙＭｅｄｉｃａｌＣｅｎｔｅｒＲｏｔｔｅｒｄａｍ	微小残存病変を検出するための方法、試薬およびキット。
SI2928923T1 (sl) *	2012-12-10	2020-03-31	Biogen Ma Inc.	Protitelesa proti antigenu 2 dendritičnih celic v krvi in njihova uporaba
AU2014302082B2 (en)	2013-06-28	2019-08-08	Baylor Research Institute	Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
EP3094652B1 (en)	2014-01-13	2021-09-29	Baylor Research Institute	Novel vaccines against hpv and hpv-related diseases
SG11201607746QA (en)	2014-03-21	2016-10-28	Abbvie Inc	Anti-egfr antibodies and antibody drug conjugates
US11034749B2 (en)	2015-07-28	2021-06-15	The Trustees Of The University Of Pennsylvania	Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
CN105510598A (zh) *	2015-12-31	2016-04-20	中国科学院海洋研究所	长牡蛎CgNatterin-3重组蛋白的应用
WO2017201635A1 (zh) *	2016-05-23	2017-11-30	蔡胜和	透明质酸酶的细胞表达及其在实体瘤细胞治疗中的应用
BR112018075630A2 (pt)	2016-06-08	2019-03-19	Abbvie Inc.	anticorpos anti-cd98 e conjugados de fármaco de anticorpo
CA3027044A1 (en)	2016-06-08	2017-12-14	Abbvie Inc.	Anti-b7-h3 antibodies and antibody drug conjugates
MX2018015285A (es)	2016-06-08	2019-09-18	Abbvie Inc	Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco.
ES2861499T3 (es)	2016-06-08	2021-10-06	Abbvie Inc	Anticuerpos anti-B7-H3 y conjugados anticuerpo-fármaco
KR102590454B1 (ko)	2016-07-07	2023-10-17	더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티	항체-애쥬번트 접합체
CA3039348C (en) *	2016-10-21	2023-09-05	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods for promoting t cells response
CN110234348B (zh)	2016-12-16	2024-06-25	蓝鳍生物医药公司	抗-含cub结构域蛋白1(cdcp1)抗体、抗体药物缀合物及其使用方法
EP3612567B1 (en)	2017-04-19	2024-09-11	Bluefin Biomedicine, Inc.	Anti-vtcn1 antibodies and antibody drug conjugates
CN118994394A (zh)	2017-06-12	2024-11-22	蓝鳍生物医药公司	抗-il1rap抗体和抗体药物缀合物
AU2018290880A1 (en) *	2017-06-28	2020-01-16	The Board Of Trustees Of The Leland Stanford Junior University	Methods and compositions for Dectin-2 stimulation and cancer immunotherapy
CN117004573A (zh) *	2017-12-13	2023-11-07	苏州康聚生物科技有限公司	一种包含肿瘤抗原识别受体的免疫细胞及其应用
JP2022525594A (ja)	2019-03-15	2022-05-18	ボルトバイオセラピューティクス、インコーポレーテッド	Ｈｅｒ２を標的とする免疫結合体
CN110373385A (zh) *	2019-07-12	2019-10-25	赛德特生物科技开发有限公司	改善神经细胞功能的免疫细胞培养基及其制备方法与应用
MX2022015062A (es)	2020-06-04	2023-04-10	Carisma Therapeutics Inc	Nuevas construcciones para receptores de antígenos quiméricos.
AR124681A1 (es)	2021-01-20	2023-04-26	Abbvie Inc	Conjugados anticuerpo-fármaco anti-egfr
CN114315990B (zh) *	2022-03-10	2022-05-27	北京康乐卫士生物技术股份有限公司	新型冠状病毒特异性单克隆抗体的制备及其应用
WO2025027529A1 (en)	2023-07-31	2025-02-06	Advesya	Anti-il-1rap antibody drug conjugates and methods of use thereof
WO2025126157A1 (en)	2023-12-15	2025-06-19	Advesya	Anti-il-1rap binding domains and antibody-drug conjugates thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL154600B (nl) *	1971-02-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3949064A (en) *	1973-10-26	1976-04-06	Baxter Laboratories, Inc.	Method of detecting antigens or antibodies
US4174384A (en) *	1975-06-30	1979-11-13	Syva Company	Fluorescence quenching with immunological pairs in immunoassays
US4554101A (en) *	1981-01-09	1985-11-19	New York Blood Center, Inc.	Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US20040258688A1 (en) *	1995-01-31	2004-12-23	Daniel Hawiger	Enhanced antigen delivery and modulation of the immune response therefrom
US6046158A (en) *	1996-12-20	2000-04-04	Board Of Regents The University Of Texas Systems	Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof
US6541011B2 (en) *	1998-02-11	2003-04-01	Maxygen, Inc.	Antigen library immunization
US5945308A (en) *	1998-04-03	1999-08-31	Incyte Pharmaceuticals, Inc.	Human oxidized LDL receptor
AU2003213640A1 (en) *	2002-02-28	2003-09-16	Corixa Corporation	Methods of modulating dendritic cells using adjuvants
US20040091503A1 (en) *	2002-08-20	2004-05-13	Genitrix, Llc	Lectin compositions and methods for modulating an immune response to an antigen
US7666596B2 (en) *	2005-05-23	2010-02-23	University Of Alberta	Tissue rejection
BRPI0807344A2 (pt) *	2007-02-02	2014-05-20	Baylor Res Inst	Antígenos multivariáveis complexados com anticorpo monoclonal humanizado de direcionamento

2008
- 2008-02-22 BR BRPI0807613-8A2A patent/BRPI0807613A2/pt not_active IP Right Cessation
- 2008-02-22 KR KR1020097019380A patent/KR20090118981A/ko not_active Withdrawn
- 2008-02-22 CA CA2717656A patent/CA2717656A1/en not_active Abandoned
- 2008-02-22 US US12/036,095 patent/US20080254047A1/en not_active Abandoned
- 2008-02-22 MX MX2009008918A patent/MX2009008918A/es not_active Application Discontinuation
- 2008-02-22 EP EP08743530A patent/EP2129692A4/en not_active Withdrawn
- 2008-02-22 WO PCT/US2008/054785 patent/WO2008103947A2/en not_active Ceased
- 2008-02-22 AU AU2008218184A patent/AU2008218184B2/en not_active Expired - Fee Related
- 2008-02-22 NZ NZ595319A patent/NZ595319A/xx not_active IP Right Cessation
- 2008-02-22 CN CN200880013398A patent/CN101668777A/zh active Pending
- 2008-02-22 TW TW097106267A patent/TW200900078A/zh unknown
- 2008-02-22 CN CN2012100181027A patent/CN102586186A/zh active Pending
- 2008-02-22 JP JP2009551042A patent/JP2010519313A/ja active Pending
- 2008-02-22 NZ NZ579238A patent/NZ579238A/en not_active IP Right Cessation
2009
- 2009-08-20 IL IL200526A patent/IL200526A0/en unknown
- 2009-09-22 ZA ZA200906618A patent/ZA200906618B/xx unknown
2011
- 2011-12-05 IL IL216778A patent/IL216778A0/en unknown

Also Published As

Publication number	Publication date
NZ595319A (en)	2012-09-28
AU2008218184B2 (en)	2013-01-10
IL216778A0 (en)	2012-01-31
TW200900078A (en)	2009-01-01
EP2129692A4 (en)	2010-12-15
JP2010519313A (ja)	2010-06-03
ZA200906618B (en)	2010-06-30
EP2129692A2 (en)	2009-12-09
IL200526A0 (en)	2010-04-29
WO2008103947A3 (en)	2008-11-27
CN101668777A (zh)	2010-03-10
US20080254047A1 (en)	2008-10-16
NZ579238A (en)	2012-04-27
CA2717656A1 (en)	2008-08-28
AU2008218184A1 (en)	2008-08-28
CN102586186A (zh)	2012-07-18
WO2008103947A2 (en)	2008-08-28
MX2009008918A (es)	2009-09-14
KR20090118981A (ko)	2009-11-18

Publication	Publication Date	Title
BRPI0807613A2 (pt)	2014-06-10	Ativação de antígeno humano presente em células através de clec-6
BRPI0821262A2 (pt)	2015-06-16	Célula fotovoltaica e dispositivo fotovoltaico
BRPI0807160A2 (pt)	2018-09-25	vacinas baseadas no direcionamento de antígeno ao dcir expresso em células apresentadoras de antígeno
DK2222706T3 (da)	2014-07-07	Antibodies against human nkg2d and uses thereof
IL213353A (en)	2017-04-30	Anti-pd-l1 antibodies and their use to enhance t-cell function
EP2232690A4 (en)	2014-01-08	PARALLEL SWITCHED INVERTER
EP2352816A4 (en)	2012-12-12	HUMAN TEMPORARY CELLS
EP2207803A4 (en)	2010-11-24	Cd9-specific human antibodies
FR2928157B1 (fr)	2010-02-26	Module de cellule habitable et cellule habitable correspondante
BRPI0818349A2 (pt)	2015-04-07	Dispositivo de reconstrução
IL212856A (en)	2016-09-29	Human antibodies against human tissue factor, conjugates and uses thereof
PL2949666T3 (pl)	2019-07-31	Ludzkie przeciwciała przeciwko alfa-synukleinie
BRPI0816956A2 (pt)	2015-03-24	Célula de combustível
EP2212725A4 (en)	2013-08-07	LIGHT CONCENTRATOR STRUCTURES AND METHOD
FR2929217B1 (fr)	2010-06-11	Dispositif de connexion en deux parties
EP2287239A4 (en)	2013-03-06	POLYIMIDE METAL LAMINATE AND SOLAR CELL
BRPI0814572A2 (pt)	2015-01-20	Célula de lítio
BRPI0923652A2 (pt)	2016-10-18	diagnóstico e tratamento de câncer usando anticorpo anti-lgr7
BRPI1008083A2 (pt)	2016-10-11	linhagem de células humanas permanentes inéditas
EP2356145A4 (en)	2012-07-18	COMPLETE HUMAN ANTIBODIES AGAINST N-CADHERINE
EP2147290A4 (en)	2013-09-25	METHOD FOR PREPARING A CELL SAMPLE AND APPARATUS THEREOF
DE602008003994D1 (de)	2011-02-03	Fahrzeugsitz-Schiebevorrichtung
BRPI0813726A2 (pt)	2014-12-30	Célula de lítio
FI20075699A0 (fi)	2007-10-03	Polttokennolaitteisto
EP2210039A4 (en)	2012-10-10	APPARATUS AND METHOD FOR HYBRID ILLUMINATION

Legal Events

Date	Code	Title	Description
2014-08-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 6A ANUIDADE.
2014-12-30	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2277 DE 26/08/2014.